Clinical Efficacy and Safety Evaluation of Fecal Bacteria Transplantation by Different Ways on Ulcerative Colitis

Xiaolin LIU; Xiaocui CHEN; Yang SUN; Minli LI; Yinglei MIAO

doi:10.12259/j.issn.2095-610X.S20220612

Volume 43 Issue 6

Jun. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(6): 46-51

Xiaolin LIU, Xiaocui CHEN, Yang SUN, Minli LI, Yinglei MIAO. Clinical Efficacy and Safety Evaluation of Fecal Bacteria Transplantation by Different Ways on Ulcerative Colitis[J]. Journal of Kunming Medical University, 2022, 43(6): 46-51. doi: 10.12259/j.issn.2095-610X.S20220612

Citation:

Xiaolin LIU, Xiaocui CHEN, Yang SUN, Minli LI, Yinglei MIAO. Clinical Efficacy and Safety Evaluation of Fecal Bacteria Transplantation by Different Ways on Ulcerative Colitis[J]. Journal of Kunming Medical University, 2022, 43(6): 46-51. doi: 10.12259/j.issn.2095-610X.S20220612

Citation:

Xiaolin LIU, Xiaocui CHEN, Yang SUN, Minli LI, Yinglei MIAO. Clinical Efficacy and Safety Evaluation of Fecal Bacteria Transplantation by Different Ways on Ulcerative Colitis[J]. Journal of Kunming Medical University, 2022, 43(6): 46-51. doi: 10.12259/j.issn.2095-610X.S20220612

PDF( 692 KB)

Clinical Efficacy and Safety Evaluation of Fecal Bacteria Transplantation by Different Ways on Ulcerative Colitis

doi: 10.12259/j.issn.2095-610X.S20220612

Yunnan Province Clinical Research Center for Digestive Disease/Dept. of Gastroenterology，The 1st Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032，China

Received Date: 2022-03-24
Publish Date: 2022-06-25

Abstract

Abstract

Objective To evaluate the efficacy and safety of upper and lower alimentary canal fecal bacteria transplantation in the treatment of ulcerative colitis, in order to guide clinical practice. Methods A total of 74 patients with mild to moderate active ulcerative colitis admitted to the Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University from October 2019 to September 2021 were selected, and they were randomly divided into two groups, including 2 cases of mid-course loss, 35 cases in the upper gastrointestinal tract pathway group and 37 cases in the lower gastrointestinal tract pathway group. Patients were evaluated with a modified Mayo Score. Results Mayo score of UC patients in both groups decreased after FMT treatment （P < 0.05）, and colonoscopy showed that mucosal inflammation, such as hyperemia, edema, erosion and ulcer, was improved compared with before treatment. There was no significant difference in Mayo Risk score between 2 groups before and after treatment （ P > 0.05）. Conclusion Fecal bacteria transplantation has a certain effect on the treatment of UC, and is safe and reliable. Fecal bacteria transplantation through upper gastrointestinal tract is as effective as that through lower gastrointestinal tract in the treatment of ulcerative colitis.
- Ulcerative colitis,
- Fecal bacteria transplantation,
- Transendoscopic enteral tubing,
- Clinical curative effect

FullText(HTML)

References(18)

References

[1]	Farrell D,McCarthy G,Savage E. Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease[J]. J Crohns Colitis,2016,10(3):315-322. doi: 10.1093/ecco-jcc/jjv218
[2]	Yarlas A,Rubin D T,Panes J,et al. Burden of Ulcerative Colitis on Functioning and Well-being:A Systematic Literature Review of the SF-36® Health Survey[J]. J Crohns Colitis,2018,12(5):600-609. doi: 10.1093/ecco-jcc/jjy024
[3]	Gupta A,Khanna S. Fecal Microbiota Transplantation[J]. JAMA The Journal of the American Medical Association,2017,318(1):102. doi: 10.1001/jama.2017.6466
[4]	Mc Donald L C,Gerding D N,Johnson S,et al. Clinical practice guidelines for Clostridium difficile infection in adults and children:2017 update by the Infectious Diseases Society of America(IDSA)and Society for Heahhcare Epidemiology of America(SHEA)[J]. Clin Infect Dis,2018,66(97):987-994.
[5]	Gulati M,Singh S K,Corrie L,et al. Delivery routes for faecal microbiota transplants:Available,anticipated and aspired[J]. Pharmacol Res,2020,159:104954. doi: 10.1016/j.phrs.2020.104954
[6]	Wargo J A. Modulating gut microbes[J]. Science,2020,369(6509):1302-1303.
[7]	中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年,北京)[J]. 中华消化杂志,2018,38(5):292-311. doi: 10.3760/cma.j.issn.0254-1432.2018.05.002
[8]	KÖnig J,Siebenhaar A,HÖgenauer C,et al. Consensus report:faecal microbiota transfer-clinical applications and procedures[J]. Aliment Pharmacol Ther,2017,45(2):222-239. doi: 10.1111/apt.13868
[9]	Zhang T,Long C,Cui B,et al. Colonic transendoscopic tube-delivered enteral therapy (with video):A prospective study[J]. BMC Gastroenterology,2020,20(1):135. doi: 10.1186/s12876-020-01285-0
[10]	Cammarota G,Ianiro G,Tilg H,et al. European consensus conference on faecal microbiota transplantation in clinical practice[J]. Gut,2017,66(4):569-580.
[11]	Vindigni S M,Zisman T L,Suskind D L,et al. The intestinal microbiome,barrier function,and immune system in inflammatory bowel disease:a tripartite pathophysiological circuit with implications for new therapeutic directions[J]. Therap Adv Gastroenterol,2016,9(4):606-625.
[12]	Weisshof R,El Jurdi K,Zmeter N,et al. Emerging Therapies for Inflammatory Bowel Disease[J]. Adv Ther,2018,35(11):1746-1762. doi: 10.1007/s12325-018-0795-9
[13]	Zuo T,Ng S C. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease[J]. Front Microbiol,2018,9:2247. doi: 10.3389/fmicb.2018.02247
[14]	Henson M A,Phalak P. Henson Michael A,Phalak Poonam,Microbiota dysbiosis in inflammatory bowel diseases:in silico investigation of the oxygen hypothesis[J]. BMC Syst Biol,2017,11(1):145. doi: 10.1186/s12918-017-0522-1
[15]	Heath R D,Cockerell C,Mankoo R,et al. Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders[J]. North Clin Istanb,2018,5(1):79-88.
[16]	Paramsothy S,Paramsothy R,Rubin D T,et al. Faecal microbiota transplantation for inflammatory bowel disease:A systematic review and meta-analysis[J]. J Crohns Colitis,2017,11(10):1180-1199. doi: 10.1093/ecco-jcc/jjx063
[17]	Singh S,Feuerstein J D,Binion D G,et al. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis[J]. Gastroenterology,2019,156(3):769-808. doi: 10.1053/j.gastro.2018.12.008
[18]	Sood A,Mahajan R,Singh A,et al. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis:A Pilot Study[J]. J Crohns Colitis,2019,13(10):1311-1317. doi: 10.1093/ecco-jcc/jjz060

Relative Articles(20)

Relative Articles

[1]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2025, 46(4): 1-9.
[2]	Hongbo ZHANG, Zhenlong LI, Ying LV, Yichao ZHANG, Xiangming QIU, Tingting HUANG. Comparison of Clinical Efficacy of Single-port and Double-port Video-assisted Thoracoscopic Lobectomy in the Treatment of Lung Cancer. Journal of Kunming Medical University, 2024, 45(4): 135-139. doi: 10.12259/j.issn.2095-610X.S20240419
[3]	Zhongqiang ZHANG, Lili HU, Junli CHEN. Clinical Efficacy of Intrapleural Injection of Thrombin Combined with Drainage tube Suspension in the Treatment of Refractory Pneumothorax. Journal of Kunming Medical University, 2024, 45(2): 1-6.
[4]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2024, 45(10): 36-44. doi: 10.12259/j.issn.2095-610X.S20241006
[5]	Meizi RAO, Xinyi JIANG, Jiarong MIAO. Analysis of Risk Factors for Co-Infection of Ulcerative Colitis with Epstein-barr Virus and Cytomegalovirus. Journal of Kunming Medical University, 2024, 45(11): 87-94. doi: 10.12259/j.issn.2095-610X.S20241113
[6]	Zhongshun NIE, Yinglei MIAO. Prospects of Fecal Microbiota Transplantation for Inflammatory Bowel Disease in the Context of Biological Agents. Journal of Kunming Medical University, 2024, 45(10): 147-154. doi: 10.12259/j.issn.2095-610X.S20241023
[7]	Chunling LI, Linghua LI, Xu HAN, Jie YANG, Heng ZHANG. Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine. Journal of Kunming Medical University, 2024, 45(3): 72-78. doi: 10.12259/j.issn.2095-610X.S20240311
[8]	Guili LIANG, Canmei LI, Chengfeng XING, Yunlong DONG, Juan WANG, Zi LEI, Yinglei MIAO, Danfeng LAN. Changes of Intestinal Inflammatory Injury Induced by DSS in GC-C^-/- Mice. Journal of Kunming Medical University, 2022, 43(7): 1-8. doi: 10.12259/j.issn.2095-610X.S20220712
[9]	Linling ZHU, Chenggang WANG, Hongliang YANG, Xiangling WEN. Observation of the Curative Effect of Enlarged and Opened Middle Turbinate Combined with Nerve Branch Block in Patients with Refractory Sinusitis. Journal of Kunming Medical University, 2022, 43(9): 96-100. doi: 10.12259/j.issn.2095-610X.S20220919
[10]	Bohan XIONG, Yihua QIN, Ziwen NING, Xu WANG, Zhengliang SHI, Xiaojun LU, Yaozhang ZHANG, Kun WANG. Effect Analysis of Single Channel Carpal Tunnel Release under Carpal Arthroscopy in the Treatment of Carpal Tunnel Syndrome. Journal of Kunming Medical University, 2022, 43(10): 57-61. doi: 10.12259/j.issn.2095-610X.S20221019
[11]	Yanfei WANG, Juan MA, Yunqiao YANG. Clinical Efficacy and Safety of Sacubatril Valsartan in Patients with Reduced Ejection Fraction Combined with Hypotensive Heart Failure. Journal of Kunming Medical University, 2022, 43(11): 136-140. doi: 10.12259/j.issn.2095-610X.S20221117
[12]	Mishra Prashant, Li Jiong Ming . Application of Laparoscopic and Robotic Ileal Uureteral Replacement Feasibility and Clinical Efficacy. Journal of Kunming Medical University, 2018, 39(03): 125-131.
[13]	Chen Xiao Hong . Influence of Continuous Nursing Intervention on Psychological Quality and Medication Compliance in Ulcerative Colitis Patients after Discharge. Journal of Kunming Medical University,
[14]	Geng Yu Liu . . Journal of Kunming Medical University,
[15]	Gu Yong Fang . . Journal of Kunming Medical University,
[16]	Kang Ying Hong . . Journal of Kunming Medical University,
[17]	Ai Jia . . Journal of Kunming Medical University,
[18]	Li Hong Li . . Journal of Kunming Medical University,
[19]	Chen Qiu . . Journal of Kunming Medical University,
[20]	Li Shuang Xi . . Journal of Kunming Medical University,